Reuters Pharma Europe 2024 – Peter Stenico
Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.
Newsletters and Deep Dive digital magazine
Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.
Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
AI is changing workflows for all kinds of pharma stakeholders, including sales representatives and medical affairs liaisons.
Cell and gene therapies were a major topic of discussion this year at Reuters Pharma USA in Philadelphia.
Most of the exciting work being done right now in cancer immunotherapy is centred on highly targeted approaches that aim to activate only the most necessary immune responses to eliminate a
Editor's Picks
Newsletters and Deep Dive
digital magazine